About The Lancet Respiratory Medicine

About the journal

The Lancet Respiratory Medicine launched in March 2013 as the fourth Lancet specialty journal following in the footsteps of The Lancet Oncology, The Lancet Neurology, and The Lancet Infectious Diseases. The journal offers the same unique fast track experience offered by its sister journals for all authors of research papers that are selected for peer review, where articles can be published online within 8 weeks of submission. The Lancet Respiratory Medicine is indexed in PubMed, and has been approved for indexing and abstracting in SciSearch®, Journal Citation Reports, and Current Contents® by Thomson Reuters.

Reputation and Impact

The Lancet Respiratory Medicine has an Impact Factor of 25.094® (2019 Journal Citation Reports®, Clarivate Analytics 2020), and is ranked as the number one journal in the fields of critical care and respiratory medicine (2019 Journal Citation Reports®, Clarivate Analytics 2020). The journal provides an authoritative and independent forum for the highest quality research, reviews, and news in all areas of global respiratory medicine or critical care with a particular focus on research that will have an impact on clinical practice.

Information for Authors

The Lancet Respiratory Medicine considers any original research contribution that advocates change in or illuminates clinical practice and informative reviews on any topic connected with respiratory medicine and critical care. Because the journal has an international readership from a wide range of specialties, it is vital that articles should be written clearly Figures and good quality photographs should be used to supplement and to enhance the text. Further details on the different sections of The Lancet Respiratory Medicine, and how to submit to the journal, are provided below. If you require further clarification, the journal’s editorial staff will be pleased to help (email [email protected]).

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

Manuscript submission

To submit your manuscript to The Lancet Respiratory Medicine please visit : http://www.editorialmanager.com/thelancetrm

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About our content

The journal publishes a range of article types in respiratory medicine and critical care. These include Original Research, Reviews, Personal Views, Comments, and News articles. Topics include but are not limited to asthma, ARDS, COPD, tobacco control, intensive care medicine, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, sepsis, mesothelioma, sleep medicine, thoracic and reconstructive surgery, tuberculosis, palliative medicine, influenza, pulmonary hypertension, pulmonary vascular disease and respiratory infections.

Dr Alison Rowan joined The Lancet Respiratory Medicine as Acting Deputy Editor in early 2020. She has a PhD from the Institute of Child Health and Great Ormond Street Hospital, University College London, UK. Her career in publishing began in 2003 at the Nature Publishing Group, where she held various editorial roles including Associate Editor of Nature Reviews Neuroscience, before she joined the Lancet group in 2006, initially as Senior Editor and then as Deputy Editor of The Lancet Neurology.

Dr Rebecca Craven joined The Lancet Respiratory Medicine as Deputy Editor in 2019. She completed a DPhil in the Department of Clinical Pharmacology and postdoctoral research in the Department of Clinical Neurology, University of Oxford, UK. Her editorial career began in 2001 at the Nature Publishing Group, where she worked as Copy Editor and Associate Editor of Nature Reviews Neuroscience, and as Senior Subeditor of Nature. She joined the Lancet family in 2011, working as Senior Editor and then Deputy Editor of The Lancet Neurology.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

November 2020

Volume 8, Issue 11